The breakdown by service

National health spending is tracked by category of service. The 2024 figures show where the $5.3 trillion actually went:

$1.63T
Hospital care — the single largest category, roughly 31% of all health spending
$1.11T
Physician & clinical services — about 21% of the total
$467B
Retail prescription drugs — about 9% of the total

Those three categories account for roughly 60% of all health spending. But the remaining 40% is not a rounding error — it is more than $2 trillion, and a complete picture has to account for it. Here is where the rest goes:

$710B
Nursing, home health & other residential/personal care — the long-term care category, growing as the population ages
$189B
Dental services (~4%), with another ~4% in other professional services (physical therapy, optometry, and similar)
~$540B
The cost of administering the system itself — government administration and the net cost of private insurance

The rest fills in from there: medical equipment and other products, government public health activity, and investment in structures, equipment, and research. Taken together, spending on actual patient care — everything delivered directly to a person, from the hospital bed to the prescription — comes to about 85% of the total, roughly $4.5 trillion. The other 15% is the machinery around the care: administration, the net cost of insurance, public health, and capital investment.

Hospital care has been the largest slice for decades, and it grew 8.9% in 2024. Physician and clinical services grew 8.1%. Prescription drugs, though the category that draws the most public attention, is a smaller slice than most people assume — under 10% of the total — though it grew quickly in prior years and remains a major driver of out-of-pocket frustration.

Two pieces this page hands off

This primer answers what the money is spent on. Two closely related questions get their own primers:

  • Who pays — the money above is sorted by service; the next primer sorts it by who actually finances it: government, employers, private insurance, and households.
  • The waste layer — that ~$540 billion administrative cost is not just a spending category; a large share of it is widely considered waste, and shrinking it is one of the clearest opportunities in the whole system. That case gets its own primer.
A note on prescription drugs

Drug spending is where public anger most often concentrates, and the frustration is real — but the number is more nuanced than the headlines. Retail prescription drugs are about 9% of total health spending. Brand-name drugs account for the large majority of drug spending while making up a small minority of prescriptions actually dispensed. Drugs matter enormously to the people who need them and to out-of-pocket costs, but they are not the largest driver of the national total. Hospitals and physician services are.

What the breakdown reveals

The shape of the spending is not neutral. It reflects what the system is organized to do. Hospital care and physician services — the acute, episodic, point-of-care end of medicine — dominate. This is where a system meets people at the moment something has gone wrong: the hospitalization, the procedure, the specialist visit for an established problem.

Primary care — the continuous, preventive, relationship-based care that intercepts problems before they become expensive — is a strikingly thin slice of the total. Estimates place primary care at roughly 5 to 7% of health spending, despite its outsized influence on everything downstream. The money follows the crisis, not the arc that leads to it.

Prices, not quantity

One more finding cuts against the common assumption. The US does not spend more than other countries because Americans use dramatically more care — utilization is often at or below peer-country levels. The US spends more largely because each unit of care costs more. It is a price story more than a quantity story, which matters: the problem is not that people are getting too much care. In many cases, at the level that would prevent the expensive events, they are getting too little.

The framework's reading

Where the money goes is the spending signature of a system built around breakdown. The dollars concentrate at the hospital and the specialist because that is where the system engages — after the slow, quiet, cheaper-to-intercept process has already become an acute event. The thinness of the primary-care slice is not a minor detail. It is the visible fingerprint of the execution gap this framework names: the part of care that would keep people out of the expensive end is the part the system funds least.

A system that spent more of its resources holding the arc — continuous primary care, delivered before crisis — would change the shape of this breakdown over time, moving spending upstream where it prevents rather than downstream where it rescues. That is not a claim that hospitals or specialists are the problem; they are essential, and the genuine emergencies will always need them. It is a claim about proportion, and about where a system chooses to place its attention and its money.